CA - Aurora Cannabis: Improved Financials Limited Opportunity

2024-04-24 09:30:00 ET

Summary

• Aurora Cannabis has seen growth in international medical cannabis sales, particularly in Germany and Australia.
• The company has shifted its focus to the medical cannabis business, which has higher margins but limited growth opportunities.
• ACB stock has rallied recently, but investors should be cautious, as the company may not benefit significantly from proposed cannabis regulations in Canada and the U.S.

Aurora Cannabis Overview

Over the last year, Aurora Cannabis Inc. ( ACB ) has finally turned their Canadian cannabis business into a functional business. The company has shifted to the more profitable medical cannabis business and oddly rallies with positive news on U.S. regulations focused on recreational cannabis. My investment thesis is now more Neutral on the stock going forward due to the limited opportunities in medical cannabis and the stock soaring 18% back above $7 on April 23....

For further details see: